TELA Bio, Inc. files DEF 14A

TELA Bio, Inc. is holding its 2026 Annual Meeting of Stockholders on June 9, 2026, to elect three Class I directors, ratify KPMG LLP as its independent auditor, approve named executive officer compensation on an advisory basis, and approve an amendment to the 2019 Equity Incentive Plan to increase authorized shares by 3,500,000. The Board recommends a "FOR" vote on all proposals.